JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
84 hedge funds and large institutions have $64.1M invested in Jounce Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 85 → 84 (-1)
Holders
84
Holding in Top 10
–
Calls
$136K
Puts
$10K
Top Buyers
| 1 | +$9.81M | |
| 2 | +$5.85M | |
| 3 | +$5.33M | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$2.01M |
| 5 |
ACM
Ardent Capital Management
Cincinnati,
Ohio
|
+$1.71M |
Top Sellers
| 1 | -$5.99M | |
| 2 | -$5.67M | |
| 3 | -$4.05M | |
| 4 |
Morgan Stanley
New York
|
-$2.85M |
| 5 |
Millennium Management
New York
|
-$2.46M |